ICD therapy reduces all-cause mortality amongst patients at high risk of SCA, claims new study
Claimed to be the largest prospective study of patients at risk of SCA in emerging countries with 4,000 study patients from 17 countries including India, the IMPROVE SCA study evaluated the risk of ventricular arrhythmias (type of high heart rate) and the mortality benefit of implantable cardioverter-defibrillator (ICD) therapy